Antiviral CD4<sup>+</sup> T and myeloid cell responses to influenza vaccines are attenuated in older adults.

BACKGROUND: Recent influenza vaccine formulations have improved the magnitude of B-cell antibody responses in older adults; however, older adults remain significantly at risk for severe influenza-related illness. Although antibodies are an important metric of vaccine effectiveness, they only represent one aspect of the immune response. METHODS: T cell, and myeloid cell responses to influenza vaccine antigens at the serologic and single-cell level. RESULTS: T cells and reduced antiviral-associated T helper cell populations. Single-cell transcriptomics revealed that older adults had attenuated interferon transcriptional signatures in T helper and myeloid cell subsets. CONCLUSIONS: These data suggest that with aging, transcriptional programming alterations in myeloid and T cells contribute to reduced antiviral responses, and formulating vaccines tailored to cellular immune responses is necessary to improve outcomes in older adults.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2026-04-17
DOI
https://doi.org/10.1038/s43856-026-01586-7
Primary Topic
Influenza Virus Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Antiviral CD4+ T and myeloid cell responses to influenza vaccines are attenuated in older adults.

Jared Oakes, Samuel Bailin, Spyros A. Kalams, Jessica L. Castilho et al.
PubMed
Influenza Virus Research Studies
article

Antiviral CD4+ T and myeloid cell responses to influenza vaccines are attenuated in older adults.

Jared Oakes, Samuel Bailin, Spyros A. Kalams, Jessica L. Castilho, Leslie Kirk, Joan Eason, Joshua D. Simmons, Cindy Hager-Nochowicz, H Keipp Talbot, Natasha B Halasa
article en

Abstract

BACKGROUND: Recent influenza vaccine formulations have improved the magnitude of B-cell antibody responses in older adults; however, older adults remain significantly at risk for severe influenza-related illness. Although antibodies are an important metric of vaccine effectiveness, they only represent one aspect of the immune response. METHODS: T cell, and myeloid cell responses to influenza vaccine antigens at the serologic and single-cell level. RESULTS: T cells and reduced antiviral-associated T helper cell populations. Single-cell transcriptomics revealed that older adults had attenuated interferon transcriptional signatures in T helper and myeloid cell subsets. CONCLUSIONS: These data suggest that with aging, transcriptional programming alterations in myeloid and T cells contribute to reduced antiviral responses, and formulating vaccines tailored to cellular immune responses is necessary to improve outcomes in older adults.

PubMed
Vanderbilt University Medical Center (US)
Good health and well-being
Openalex Percentile: Top 19%
Influenza Virus Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.